Structural Biology News and Research

RSS

NTU scientists design new compound that could help reduce overactive immune response

When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself, which may prove fatal in some cases.

10 Mar 2021

Tiny antibodies naturally generated by llamas can be effective against COVID-19

As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas.

10 Mar 2021

New compound can reduce overactivation without impairing the body's immunity response

10 Mar 2021

Direct electron introduces Apollo

Direct Electron, a leading producer of next-generation direct detection cameras for transmission electron microscopes (TEM), today announces Apollo, a revolutionary new event-based direct detection camera for electron cryo-microscopy (cryo-EM). Based on a next generation sensor and camera architecture delivering electron counting in hardware, Apollo is the highest throughput direct detector for cryo-EM.

From Direct Electron, LP 4 Mar 2021

New insights on structural biology may help design more efficient antibodies

In structural biology, some molecules are so unusual they can only be captured with a unique set of tools.

18 Feb 2021

Bruker establishes new customer support center in the Middle East at King Abdullah University of Science and Technology Research Park

Bruker Corporation and King Abdullah University of Science and Technology (KAUST) jointly announced the establishment of the Bruker Arabia office at the KAUST Research and Technology Park, furthering the trusted partnership between the two organizations.

From Bruker BioSpin - NMR, EPR and Imaging 8 Feb 2021

Study finds structural similarities between SARS-CoV-2 and pangolin coronavirus

Scientists at the Francis Crick Institute have found important structural similarities between SARS-CoV-2 and a pangolin coronavirus, suggesting that a pangolin coronavirus could infect humans.

7 Feb 2021

New process separates beneficial glucocorticoids from unwanted side-effects

A collaboration led by Scripps Research has developed a way to separate the beneficial anti-inflammatory properties of a group of steroids called glucocorticoids from some of their unwanted side-effects, through an optimization process they named "ligand class analysis."

3 Feb 2021

SPT Labtech announces acquisition of Apricot Designs

SPT Labtech announces the acquisition of Apricot Designs Inc., headquartered in Covina, California.

From SPT Labtech 21 Jan 2021

Researchers discover antibody that blocks the spread of dengue virus

A team of researchers led by the University of California, Berkeley and the University of Michigan has discovered an antibody that blocks the spread within the body of the dengue virus, a mosquito-borne pathogen that infects between 50 and 100 million people a year.

14 Jan 2021

Biologists reveal unusual structure of coronavirus protein linked to immune evasion

A team of HIV researchers, cellular biologists, and biophysicists who banded together to support COVID-19 science determined the atomic structure of a coronavirus protein thought to help the pathogen evade and dampen response from human immune cells.

13 Jan 2021

Researchers determine the atomic structure of protein that helps coronavirus to evade immune cells

12 Jan 2021

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Mogrify Limited and the MRC Laboratory of Molecular Biology (LMB), today announced an exploratory research collaboration.

11 Jan 2021

Severity of COVID-19 correlates with the ratio of antibodies targeting crucial viral protein

COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.

24 Dec 2020

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States.

18 Dec 2020

Predicting SARS-CoV-2 protein sequences

SARS-CoV-2, the causative agent of COVID-19, consists of an assembly of proteins that determine its infectious and immunological behavior.

9 Dec 2020

Amilorides reduce SARS-CoV-2 viral replication in vitro

A new U.S. study published on the bioRxiv preprint server reports the use of an amiloride-based scaffold that targets a viral RNA structure known to be essential in viral replication in the 5’-untranslated region (UTR) of the virus. The researchers say this heralds the application of these molecules as chemical probes to explore viral biology and produce specific antivirals targeting RNA regions of the coronavirus genome.

8 Dec 2020

Researchers use advanced methods to investigate structure and interactions of proteins

Michael Gross, professor of chemistry in Arts & Sciences at Washington University in St. Louis and of immunology and internal medicine at the School of Medicine, and his team are experts in footprinting proteins -- that is, using advanced methods for investigating the structure and interactions of proteins within larger molecules.

8 Dec 2020

Researchers devise new molecular imaging strategy to observe the sperm selection process

A protein called CatSper1 may act as a molecular 'barcode' that helps determine which sperm cells will make it to an egg and which are eliminated along the way.

2 Dec 2020

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

A team of San Diego Supercomputer Center (SDSC) researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19.

2 Dec 2020

Structural Biology News and Research

NTU scientists design new compound that could help reduce overactive immune response

Tiny antibodies naturally generated by llamas can be effective against COVID-19

New compound can reduce overactivation without impairing the body's immunity response

Direct electron introduces Apollo

New insights on structural biology may help design more efficient antibodies

Bruker establishes new customer support center in the Middle East at King Abdullah University of Science and Technology Research Park

Study finds structural similarities between SARS-CoV-2 and pangolin coronavirus

New process separates beneficial glucocorticoids from unwanted side-effects

SPT Labtech announces acquisition of Apricot Designs

Researchers discover antibody that blocks the spread of dengue virus

Biologists reveal unusual structure of coronavirus protein linked to immune evasion

Researchers determine the atomic structure of protein that helps coronavirus to evade immune cells

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Severity of COVID-19 correlates with the ratio of antibodies targeting crucial viral protein

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

Predicting SARS-CoV-2 protein sequences

Amilorides reduce SARS-CoV-2 viral replication in vitro

Researchers use advanced methods to investigate structure and interactions of proteins

Researchers devise new molecular imaging strategy to observe the sperm selection process

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News